Post Traumatic Stress DisorderNCT07710573
Brief SEE FAR CBT Intervention Compared With Treatment as Usual for Adults With PTSD
A study testing Brief SEE FAR CBT Intervention and Dynamic Psychotherapy Treatment as Usual in people with Post Traumatic Stress Disorder, run by Community Stress Prevention Center at 1 site in Israel.
Trial summary
This clinical intervention study evaluates a newly developed Brief SEE FAR CBT protocol for adults aged 18 years and older with posttraumatic stress disorder (PTSD), compared with dynamic psychotherapy treatment as usual. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Post Traumatic Stress Disorder
- What is being tested?
- Brief SEE FAR CBT Intervention and Dynamic Psychotherapy Treatment as Usual
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteIsrael
- Study dates
- Jul 2026to Mar 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Participants must meet all of the following criteria:
- Age 18 years or older
- PTSD symptoms, defined as a PCL-5 score of 30-60
- Hebrew-speaking
- Able to provide informed consent
- Willing and able to participate in the assigned psychological intervention and complete study questionnaires at baseline, after 6 sessions, after 12 sessions, and at 3-month follow-up Exclusion Criteria
Show all 10Show fewer
- Participants will be excluded if they meet any of the following criteria:
- Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes
- Currently receiving psychotherapy of any type that began less than 3 months prior to enrollment
- Initiation of psychiatric medication less than 3 months prior to enrollment
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Israel1 site, 1 recruiting
- Recruiting
The Center for Psychological Services Sha'ar Hanegev
Sha'ar Hanegev
Tal Eilon, 972-77-9802751, tale@mpsy.org.il
About this study
Official title: A Clinical Study Evaluating the Effects of a Brief SEE FAR CBT Intervention Compared With Dynamic Psychotherapy Treatment as Usual on Psychological Outcomes in Adults With Posttraumatic Stress Disorder
This clinical intervention study evaluates a newly developed Brief SEE FAR CBT protocol for adults aged 18 years and older with posttraumatic stress disorder (PTSD), compared with dynamic psychotherapy treatment as usual. Participants in the Brief SEE FAR CBT group will receive 6 focused sessions emphasizing intrusive PTSD symptoms and will then continue to complete the full 12-session SEE FAR CBT protocol. Participants in the control group will receive dynamic psychotherapy as treatment as usual. Psychological outcomes will be assessed using self-report questionnaires at four time points: baseline, after 6 sessions, after 12 sessions, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms, anxiety, depression, perceived stress, resilience, somatic symptoms, sleep quality, and related psychological outcomes over the course of treatment and follow-up.
- Conditions
- Post Traumatic Stress Disorder
- Being tested
- Brief SEE FAR CBT Intervention, Dynamic Psychotherapy Treatment as Usual
- Keywords
- PTSD, Brief SEE FAR CBT, Intervention
- Medical subject headings
- Stress Disorders, Post-Traumatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Brief SEE FAR CBT InterventionBehavioural
Brief SEE FAR CBT is a focused trauma-oriented cognitive-behavioral intervention based on the SEE FAR CBT approach. The brief protocol consists of 6 sessions delivered approximately once weekly, with emphasis on intrusive PTSD symptoms. Participants will then continue treatment to complete the full 12-session SEE FAR CBT protocol.
Dynamic Psychotherapy Treatment as UsualBehavioural
Participants will receive dynamic psychotherapy as treatment as usual, delivered approximately once weekly. This comparison condition represents the standard psychological treatment provided to participants in this clinical setting.
| Study group | Role | What they receive |
|---|---|---|
| Brief SEE FAR CBT Intervention | Experimental | Participants in this arm will receive 6 focused sessions of Brief SEE FAR CBT, a newly developed protocol emphasizing intrusive PTSD symptoms. After completing the 6 focused sessions, participants will continue to complete the full 12-session SEE FAR CBT protocol. Receives: Behavioral: Brief SEE FAR CBT Intervention |
| Dynamic Psychotherapy Treatment as Usual | Experimental | Participants in this arm will receive dynamic psychotherapy as treatment as usual, delivered approximately once weekly. Receives: Behavioral: Dynamic Psychotherapy Treatment as Usual |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in PTSD symptoms
PTSD Checklist for DSM-5 (PCL-5) PTSD symptoms will be assessed using the PCL-5. Total scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity. Change in PCL-5 total score will be examined from baseline to after 6 sessions, from baseline to after 12 sessions, from baseline to 3-month follow-up, from after 6 sessions to after 12 sessions, and from after 12 sessions to 3-month follow-up.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in anxiety symptoms
Generalized Anxiety Disorder-7 (GAD-7) Anxiety symptoms will be assessed using the GAD-7. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Change in GAD-7 total score will be examined from baseline to after 6 sessions, from baseline to after 12 sessions, from baseline to 3-month follow-up, from after 6 sessions to after 12 sessions, and from after 12 sessions to 3-month follow-up.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Secondary outcomes (7)
Change in depressive symptoms
Patient Health Questionnaire-9 (PHQ-9) Depressive symptoms will be assessed using the PHQ-9. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Change in PHQ-9 total score will be examined across the four study assessment points.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in perceived stress
Perceived Stress Scale (PSS) Perceived stress will be assessed using the PSS. Total scores range from 0 to 40, with higher scores indicating greater perceived stress. Change in PSS total score will be examined across the four study assessment points.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in resilience
Connor-Davidson Resilience Scale (CD-RISC) esilience will be assessed using the CD-RISC. Total scores range from 0 to 40, with higher scores indicating greater resilience. Change in CD-RISC total score will be examined across the four study assessment points.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in somatic symptoms
Patient Health Questionnaire-15 (PHQ-15) Somatic symptoms will be assessed using the PHQ-15. Total scores range from 0 to 30, with higher scores indicating greater somatic symptom severity. Change in PHQ-15 total score will be examined across the four study assessment points.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in trauma-related use of imagination and coping
FRAME Trauma-related use of imagination and coping will be assessed using the FRAME questionnaire. The FRAME is a 21-item measure of fantastic reality ability, defined as the capacity to use imagination in response to stress or trauma. Items are rated on a 1-7 Likert scale, and mean scores range from 1 to 7, with higher scores indicating greater fantastic reality ability. Change in FRAME score will be examined across the four study assessment points.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in sleep quality
Brief Version of the Pittsburgh Sleep Quality Index Sleep quality will be assessed using the brief version of the Pittsburgh Sleep Quality Index. Change in sleep quality score will be examined across the four study assessment points.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in PTSD-related functional impairment
PTSD-related functional impairment will be assessed using the functional impairment section of the Posttraumatic Diagnostic Scale (PDS). This section includes 7 items assessing the extent to which PTSD-related problems interfered with work, relationships, leisure activities, family relationships, sex life, general life satisfaction, and overall functioning during the past two weeks. Items are rated from 0 to 4, and total scores range from 0 to 28, with higher scores indicating greater functional impairment. Change in functional impairment score will be examined across the four study assessment points.
Measured: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2026
- Study startJul 2026 (estimated)
- Primary completionDec 2027 (estimated)
- Study completionMar 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post Traumatic Stress DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be assigned to one of two parallel groups. One group will receive the Brief SEE FAR CBT protocol followed by completion of the full 12-session SEE FAR CBT protocol. The comparison group will receive dynamic psychotherapy as treatment as usual.
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Community Stress Prevention Center
- Sponsor type
- University, hospital or other
- Collaborators
- Tel Hai College, The Center for Psychological Services Sha'ar Hanegev
- Responsible party
- Sponsor
- Investigators
- Meital Mashash, PhD, Principal investigator, Community Stress Prevention CenterSivan Raz, PhD, Principal investigator, Tel Hai College
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07710573
- Sponsor's protocol ID
- BRIEF-SEE-FAR-CBT-PTSD-2026
- Status last verified
- Jun 2026
- First submitted
- 1 Jul 2026
- Last updated
- 17 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared due to the sensitive clinical nature of the data and participant privacy considerations.
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Study Evaluating the Effects of a Brief SEE FAR CBT Intervention Compared With Dynamic Psychotherapy Treatment as Usual on Psychological Outcomes in Adults With Posttraumatic Stress Disorder
- ClinicalTrials.gov ID
- NCT07710573
- Acronym / sponsor ID
- BRIEF-SEE-FAR-CBT-PTSD-2026
- Conditions
- Post Traumatic Stress Disorder
- Keywords
- PTSD, Brief SEE FAR CBT, Intervention
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Community Stress Prevention CenterUniversity, hospital or other
- Collaborators
- Tel Hai College, The Center for Psychological Services Sha'ar Hanegev
- Study start
- Jul 2026 (estimated)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Mar 2028 (estimated)
- First posted
- 17 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical intervention study evaluates a newly developed Brief SEE FAR CBT protocol for adults aged 18 years and older with posttraumatic stress disorder (PTSD), compared with dynamic psychotherapy treatment as usual. Participants in the Brief SEE FAR CBT group will receive 6 focused sessions emphasizing intrusive PTSD symptoms and will then continue to complete the full 12-session SEE FAR CBT protocol. Participants in the control group will receive dynamic psychotherapy as treatment as usual. Psychological outcomes will be assessed using self-report questionnaires at four time points: baseline, after 6 sessions, after 12 sessions, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms, anxiety, depression, perceived stress, resilience, somatic symptoms, sleep quality, and related psychological outcomes over the course of treatment and follow-up.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will be assigned to one of two parallel groups. One group will receive the Brief SEE FAR CBT protocol followed by completion of the full 12-session SEE FAR CBT protocol. The comparison group will receive dynamic psychotherapy as treatment as usual.
| Arm | Type | Receives |
|---|---|---|
| Brief SEE FAR CBT Intervention | Experimental | Behavioral: Brief SEE FAR CBT InterventionParticipants in this arm will receive 6 focused sessions of Brief SEE FAR CBT, a newly developed protocol emphasizing intrusive PTSD symptoms. After completing the 6 focused sessions, participants will continue to complete the full 12-session SEE FAR CBT protocol. |
| Dynamic Psychotherapy Treatment as Usual | Experimental | Behavioral: Dynamic Psychotherapy Treatment as UsualParticipants in this arm will receive dynamic psychotherapy as treatment as usual, delivered approximately once weekly. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- Age 18 years or older
- PTSD symptoms, defined as a PCL-5 score of 30-60
- Hebrew-speaking
- Able to provide informed consent
- Willing and able to participate in the assigned psychological intervention and complete study questionnaires at baseline, after 6 sessions, after 12 sessions, and at 3-month follow-up Exclusion Criteria
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Brief SEE FAR CBT InterventionBrief SEE FAR CBT is a focused trauma-oriented cognitive-behavioral intervention based on the SEE FAR CBT approach. The brief protocol consists of 6 sessions delivered approximately once weekly, with emphasis on intrusive PTSD symptoms. Participants will then continue treatment to complete the full 12-session SEE FAR CBT protocol. | Behavioural | Brief SEE FAR CBT Intervention |
| Dynamic Psychotherapy Treatment as UsualParticipants will receive dynamic psychotherapy as treatment as usual, delivered approximately once weekly. This comparison condition represents the standard psychological treatment provided to participants in this clinical setting. | Behavioural | Dynamic Psychotherapy Treatment as Usual |
Primary outcome
Change in PTSD symptoms
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
PTSD Checklist for DSM-5 (PCL-5) PTSD symptoms will be assessed using the PCL-5. Total scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity. Change in PCL-5 total score will be examined from baseline to after 6 sessions, from baseline to after 12 sessions, from baseline to 3-month follow-up, from after 6 sessions to after 12 sessions, and from after 12 sessions to 3-month follow-up.
Change in anxiety symptoms
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Generalized Anxiety Disorder-7 (GAD-7) Anxiety symptoms will be assessed using the GAD-7. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Change in GAD-7 total score will be examined from baseline to after 6 sessions, from baseline to after 12 sessions, from baseline to 3-month follow-up, from after 6 sessions to after 12 sessions, and from after 12 sessions to 3-month follow-up.
7 secondary outcomes
Change in depressive symptoms
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in perceived stress
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in resilience
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in somatic symptoms
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in trauma-related use of imagination and coping
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in sleep quality
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Change in PTSD-related functional impairment
Time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared due to the sensitive clinical nature of the data and participant privacy considerations.
Related trials for Post Traumatic Stress Disorder
Active, not recruiting
Improving Student Mental Health Through a Universal Trauma-Informed Intervention
Anxiety Symptoms, Post-traumatic Stress Symptoms
RecruitingPhase 1
Open-Label Psilocybin Study in Transdiagnostic Population
Transdiagnostic, Depression - Major Depressive Disorder
Not yet recruitingPhase 2
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
PTSD, PTSD - Post Traumatic Stress Disorder
Active, not recruitingObservational study
Trauma-Related Attributions in Trauma Treatment: An Observational Study
PTSD
Not yet recruiting
Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use
Post Traumatic Stress Disorder PTSD, Hazardous Alcohol Use
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Meital Mashash, PhD principal investigator
Community Stress Prevention Center
Sivan Raz, PhD principal investigator
Tel Hai College
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Brief SEE FAR CBT Intervention and Dynamic Psychotherapy Treatment as Usual in people with Post Traumatic Stress Disorder, run by Community Stress Prevention Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Meital Mashash, PhD (972-50-2888052, meitalm@icspc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in PTSD symptoms (time frame: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.